tPA in daily clinical practice.
Nighoghossian
Norbert
N
D019090:Case Management; D002543:Cerebral Hemorrhage / Q000139:chemically induced / Q000401:mortality; D004341:Drug Evaluation; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006297:Health Services Accessibility; D017052:Hospital Mortality; D006764:Hospitals, Community; D006782:Hospitals, Special; D006801:Humans; D015337:Multicenter Studies as Topic; D010353:Patient Education as Topic; D012306:Risk; D012449:Safety; D020521:Stroke / Q000188:drug therapy* / Q000401:mortality; D015912:Thrombolytic Therapy / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator